Frontlight ResearchEarly access
Trial site
Szpital Specjalistyczny w Prabutach Sp. z o.o.
- 16running trials
- 7closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer22 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 315 trials
- Phase 26 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting9 trials
- Active, not recruiting7 trials
- Completed7 trials
- Lead sponsor
- Merck Sharp & Dohme LLC5 trials
- Bristol-Myers Squibb4 trials
- Genmab A/S2 trials
- Amgen1 trial
- Bristol-Myers Squibb Services Unlimited Company1 trial
- and 10 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
GEN1046 Safety Trial in Patients With Malignant Solid Tumors
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026